Is immunotherapy a potential game changer in managing human papillomavirus (HPV) infection and intraepithelial neoplasia?
- PMID: 37236509
- PMCID: PMC10774942
- DOI: 10.1016/j.tvr.2023.200263
Is immunotherapy a potential game changer in managing human papillomavirus (HPV) infection and intraepithelial neoplasia?
Abstract
The International Papillomavirus Conference was held in Washington DC in April 2023 and encompassed wide ranging basic, clinical and public health research relating to animal and human papillomaviruses. This editorial is a personal reflection, it does not attempt to be comprehensive and reports on some key aspects centred on the prospects for immune interventions in prevention and treatment of HPV infections and early precancers with a focus on cervical neoplasia. There is optimism for the future impact of immunotherapy in treating early HPV associated disease. This will depend on developing an appropriate design of vaccines and delivery vehicles which then need to be properly tested in clinical trials that are able to measure a useful clinical endpoint. Thereafter vaccines (prophylactic or therapeutic) still need global access and sufficient uptake to deliver impact and a key and necessary driver is education.
Copyright © 2023.
Conflict of interest statement
Declaration of competing interest The author declares that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
References
-
- Simms K.T., Steinberg J., Caruana M., Smith M.A., Lew J.B., et al. Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study. Lancet Oncol. 2019 Mar;20(3):394–407. doi: 10.1016/S1470-2045(18)30836-2. - DOI - PubMed
-
- Bruni L., Serrano B., Roura E., Alemany L., Cowan M., et al. Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis. Lancet Global Health. 2022 Aug;10(8):e1115–e1127. doi: 10.1016/S2214-109X(22)00241-8. - DOI - PMC - PubMed
-
- Baena A., Mesher D., Salgado Y., Martínez S., Villalba G.R., et al. ESTAMPA study group. Performance of visual inspection of the cervix with acetic acid (VIA) for triage of HPV screen-positive women: results from the ESTAMPA study. Int. J. Cancer. 2023 Apr 15;152(8):1581–1592. doi: 10.1002/ijc.34384. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
